Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Kris and I will be your conference operator today.
Posts Tagged ‘NASDAQ:CPRX’
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q2 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Catalyst Pharmaceuticals' Second Quarter 2024 Financial Results Conference Call.
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Catalyst Pharmaceuticals' First Quarter 2024 Financial Results Conference Call.
Jim Cramer’s 10 Favorite Healthcare Stock Picks in 2024
In this article, we will take a detailed look at Jim Cramer’s 10 Favorite Healthcare Stock Picks in 2024. For a quick overview of such stocks, read our article Jim Cramer...
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q4 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Catalyst Pharmaceuticals Inc. Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast.
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q3 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Catalyst Pharmaceuticals Third Quarter 2023 Financial Results Conference Call and Webcast [Operator Instructions].
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q2 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Catalyst Pharmaceutical Second Quarter 2023 Financial Results Conference Call and Webcast.
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2023 Earnings Call Transcript
Operator: Greetings and welcome to the Catalyst Pharmaceuticals first quarter 2023 financial results conference call. At this time, all participants are in a listen-only mode.
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q4 2022 Earnings Call Transcript
Operator: Greetings and welcome to the Catalyst Pharmaceuticals Fourth Quarter and Full Year 2022 Financial Results Conference Call.
13 High Growth Pharma Stocks that are Profitable
One industry that has rapidly evolved with time and impacted millions, if not billions, of lives is the pharmaceutical sector.
12 Best Performing NASDAQ Stocks in 2022
The S&P 500 rose 0.6% to 3,844.82 on December 23, while the Nasdaq Composite gained 0.2% to close at 10,497.86.
12 Best Performing Biotech Stocks in 2022
Fitch Ratings has assigned a Neutral rating to the global pharmaceutical and biotech industry, which indicates the assumption of a collaborative operating backdrop in 2023, although...
5 Biotech Stocks With The Biggest Upside
In this article, we discuss the 5 biotech stocks with the biggest upside.
12 Best Small-Cap Healthcare Stocks To Buy Now
In this article, we discuss 12 best small-cap healthcare stocks to buy now.
10 Robinhood Stocks To Buy That Are Too Cheap To Ignore
In this article, we will be taking a look at 10 Robinhood stocks to buy that are too cheap to ignore.
10 Best Robinhood Stocks To Buy Right Now
In this article, we discuss 10 best Robinhood stocks to buy right now.
10 Growth Stocks Under $20 in Billionaire Ken Fisher’s Portfolio
In this article, we discuss the 10 growth stocks under $20 in billionaire Ken Fisher's portfolio.
5 New Stock Picks of Billionaire Ken Fisher
In this article, we discuss the 5 new stock picks of billionaire Ken Fisher.
5 Best Stocks for Long Term Growth
In this article, we discuss 5 best stocks for long term growth.
5 Cheap Pharmaceutical Stocks to Watch
In this article, we discuss the 5 cheap pharmaceutical stocks to watch.
10 Best Biotech Penny Stocks to Buy Now
In this article, we discuss the 10 best biotech penny stocks to buy now.
Is CPRX A Good Stock To Buy Now?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Are Crazy About Catalyst Pharmaceuticals, Inc. (CPRX)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Did Hedge Funds Make The Right Call On Catalyst Pharmaceuticals, Inc. (CPRX) ?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file ...
Hedge Funds Have Never Been This Bullish On Catalyst Pharmaceuticals, Inc. (CPRX)
In this article you are going to find out whether hedge funds think Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is a good investment right now.
Is Catalyst Pharmaceuticals, Inc. (CPRX) A Good Stock To Buy?
Before putting in our own effort and resources into finding a good investment, we can quickly utilize hedge fund expertise to give us a quick glimpse of whether that stock could...
Here is What Hedge Funds Think About Catalyst Pharmaceuticals, Inc. (CPRX)
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing...
Should You Buy Catalyst Pharmaceuticals, Inc. (CPRX)?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end...
Catalyst Pharmaceuticals Inc (CPRX) and Achillion Pharmaceuticals, Inc. (ACHN) Among Five Cheap Healthcare Stocks To Buy Now
There are plenty of opportunities to invest in healthcare stocks, as there are thousands of companies, ranging from big and well-established pharmaceuticals that also pay substantial...
13G Filing: Great Point Partners and Catalyst Pharmaceuticals Inc. (CPRX)
Please follow Great Point Partners (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Great Point Partners or update its stock...
Catalyst Pharmaceuticals Inc (CPRX): Here’s What’s Next
After struggling throughout the latter half of 2016 with various development and regulatory pressures, Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) has finally found some reprieve...
Here’s Why Traders Are Piling Into These Five Stocks
All three major indexes are in the green today as investors look forward to today's FOMC meeting decision.
Catalyst Pharmaceuticals Inc (CPRX) Isn’t Out Of The Woods With Firdapse Just Yet
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) just announced that it is carrying forward with a special protocol assessment (SPA) for its lead asset, Firdapse, for the treatment ...
Here’s Why Catalyst Pharmaceuticals, Resolute Energy, Nutanix & Two Other Stocks Are Trading Higher Today
The markets have shaken off their negative trend as major indices are trading in the green zone.
What We’re Looking For From The Catalyst Pharmaceuticals Inc (CPRX) Data
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) just reported that the FDA has granted Orphan Drug Designation to its lead development candidate, and the company is up nearly 10% on...
Noteworthy Insider Transactions at 5 Companies Amid Slowing Insider Buying as Markets Near All-Time Highs
Investors usually associate insider trading with illegal conduct, but not all insider trading activity is illegal.
Most Popular Healthcare Penny Stocks Among Hedge Funds
Although a great movie, The Wolf of Wall Street left many people thinking penny stocks are somewhat 'untouchable'.
What Has Investors Spooked About These 5 Stocks Today?
Although all three indexes are in the green and crude futures are 2% higher, shares of Capital Product Partners L.P.
Insider Buying Points To Huge Upside For These 3 Beaten-Down Stocks
Rising interest rates, a struggling Chinese economy, declining crude oil prices and a strong U.S dollar are key factors that explain the increased volatility and wild swings...
Hedge Funds Are Dumping Catalyst Pharmaceutical Partners, Inc. (CPRX)
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Is Catalyst Pharmaceutical Partners, Inc. (CPRX) a “Buy” after Its Promising Results In Proof-Of-Concept Trial Of Vigabatrin
Earlier today Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) has announced promising top-line results in proof-of-concept trial of its CPP-109 (Vigabatrin).
Catalyst Pharmaceutical Partners, Inc. (CPRX): Steven Cohen Bets on Another Biotech Development-Stage Stock
In a new filing with the Securities and Exchange Commission, Steven Cohen's Point72 Asset Management disclosed a new stake in Catalyst Pharmaceutical Partners, Inc.
Small-Cap News: Smith & Wesson Holding Corp (SWHC)’s Announcement, Mellanox Technologies, Ltd. (MLNX), Catalyst Pharmaceutical Partners, Inc. (CPRX) & China Commercial Credit Inc (CCCR)’s Loan Guarantees
Editor's Note: Related tickers: Smith & Wesson Holding Corp (NASDAQ:SWHC), Mellanox Technologies, Ltd. (NASDAQ:MLNX), Catalyst Pharmaceutical Partners, Inc.
